BMSSC
ALNY icon

B. Metzler seel. Sohn & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.19M Buy
10,591
+2,116
+25% +$638K 0.03% 323
2026
Q1 		$2.8M Buy
8,475
+3,223
+61% +$1.1M 0.03% 314
2025
Q4 		$2.09M Buy
5,252
+1,339
+34% +$593K 0.02% 390
2025
Q3 		$1.78M Buy
3,913
+680
+21% +$277K 0.02% 417
2025
Q2 		$1.05M Hold
3,233
– – 0.01% 531
2025
Q1 		$873K Sell
3,233
-46
-1% -$11.8K 0.01% 549
2024
Q4 		$772K Hold
3,279
– – 0.01% 582
2024
Q3 		$902K Sell
3,279
-738
-18% -$192K 0.01% 566
2024
Q2 		$976K Buy
4,017
+99
+3% +$15.6K 0.01% 528
2024
Q1 		$586K Buy
3,918
+190
+5% +$31.7K 0.01% 599
2023
Q4 		$714K Hold
3,728
– – 0.01% 554
2023
Q3 		$660K Buy
3,728
+37
+1% +$7.06K 0.01% 541
2023
Q2 		$701K Hold
3,691
– – 0.01% 537
2023
Q1 		$739K Buy
3,691
+367
+11% +$77.1K 0.01% 491
2022
Q4 		$790K Buy
3,324
+1,005
+43% +$214K 0.01% 470
2022
Q3 		$464K Hold
2,319
– – 0.01% 553
2022
Q2 		$338K Hold
2,319
– – 0.01% 623
2022
Q1 		$379K Hold
2,319
– – 0.01% 650
2021
Q4 		$397K Buy
2,319
+374
+19% +$69.5K 0.01% 603
2021
Q3 		$367K Hold
1,945
– – 0.01% 608
2021
Q2 		$330K Buy
1,945
+468
+32% +$68.5K ﹤0.01% 606
2021
Q1 		$209K Buy
+1,477
New +$222K ﹤0.01% 659

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

B. Metzler seel. Sohn & Co's ALNY Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co increased its Alnylam Pharmaceuticals (ALNY) stake by 25% in Q2 2026, buying an estimated $638K and bringing the position to 10,591 shares worth $3.19M. The position accounts for 0.03% of the portfolio, ranked #323.

B. Metzler seel. Sohn & Co first reported a position in ALNY in Q1 2021 and has held it in 22 quarters since. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 10,591 shares of Alnylam Pharmaceuticals worth $3.19M as of Q2 2026.
  • B. Metzler seel. Sohn & Co bought 2,116 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $638K.
  • Alnylam Pharmaceuticals made up 0.03% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #323 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Alnylam Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.